Amalgamated Bank Decreases Stock Position in Axcelis Technologies, Inc. (NASDAQ:ACLS)

Amalgamated Bank reduced its position in shares of Axcelis Technologies, Inc. (NASDAQ:ACLS) by 3.4% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 9,603 shares of the semiconductor company’s stock after selling 340 shares during the period. Amalgamated Bank’s holdings in Axcelis Technologies were worth $1,007,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also made changes to their positions in ACLS. CWM LLC lifted its holdings in Axcelis Technologies by 4.8% in the 2nd quarter. CWM LLC now owns 1,506 shares of the semiconductor company’s stock worth $214,000 after buying an additional 69 shares in the last quarter. Xponance Inc. boosted its holdings in Axcelis Technologies by 4.7% in the second quarter. Xponance Inc. now owns 2,061 shares of the semiconductor company’s stock valued at $293,000 after purchasing an additional 92 shares during the last quarter. Andina Capital Management LLC grew its stake in Axcelis Technologies by 3.7% during the 2nd quarter. Andina Capital Management LLC now owns 2,791 shares of the semiconductor company’s stock valued at $397,000 after purchasing an additional 99 shares in the last quarter. Advisors Asset Management Inc. increased its holdings in Axcelis Technologies by 17.5% during the 1st quarter. Advisors Asset Management Inc. now owns 670 shares of the semiconductor company’s stock worth $75,000 after purchasing an additional 100 shares during the last quarter. Finally, Evergreen Capital Management LLC raised its position in shares of Axcelis Technologies by 6.1% in the 2nd quarter. Evergreen Capital Management LLC now owns 1,984 shares of the semiconductor company’s stock valued at $282,000 after purchasing an additional 114 shares in the last quarter. 89.98% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of research firms have recently weighed in on ACLS. Benchmark downgraded shares of Axcelis Technologies from a “buy” rating to a “hold” rating in a research report on Friday, November 8th. Needham & Company LLC reissued a “hold” rating on shares of Axcelis Technologies in a research report on Friday, November 8th. Finally, B. Riley reduced their price target on shares of Axcelis Technologies from $190.00 to $165.00 and set a “buy” rating on the stock in a research report on Friday, August 2nd. Three analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $167.33.

Axcelis Technologies Trading Down 1.1 %

Axcelis Technologies stock opened at $78.85 on Friday. Axcelis Technologies, Inc. has a 1 year low of $78.61 and a 1 year high of $158.61. The firm’s 50-day moving average is $95.66 and its 200-day moving average is $112.87. The company has a debt-to-equity ratio of 0.04, a quick ratio of 3.29 and a current ratio of 4.45. The company has a market cap of $2.56 billion, a P/E ratio of 11.86, a PEG ratio of 2.56 and a beta of 1.60.

Axcelis Technologies Profile

Axcelis Technologies, Inc designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips in the United States, Europe, and Asia Pacific. The company offers high energy, high current, and medium current implanters for various application requirements.